Literature DB >> 11433392

MHC class Ia-restricted T cells partially account for beta2-microglobulin-dependent resistance to Mycobacterium tuberculosis.

M S Rolph1, B Raupach, H H Köbernick, H L Collins, B Pérarnau, F A Lemonnier, S H Kaufmann.   

Abstract

Recent studies have highlighted the heterogeneous nature of the CD8(+) T cell response during human Mycobacterium tuberculosis infection; MHC class Ia, MHC class Ib and CD1 have all been identified as significant restriction elements. Here we have attempted to define the role of MHC class Ia in resistance to M. tuberculosis infection in mice. The course of M. tuberculosis infection in mice deficient in a single MHC class Ia molecule, either H2-K(b) or H2-D(b), was essentially identical to that observed in wild-type mice. In contrast, mice fully deficient in MHC class Ia molecules (H2-K(b) / H2-D(b) double knockout mice) were substantially more susceptible to M. tuberculosis infection. However, the double knockout mice were not as susceptible as beta 2-microglobulin-deficient mice, which have a broader phenotypic deficit. Thus, antigen presentation via MHC class Ia is an important component in resistance to M. tuberculosis, but its absence only partially accounts for the increased susceptibility of beta 2-microglobulin-deficient mice.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11433392     DOI: 10.1002/1521-4141(200106)31:6<1944::aid-immu1944>3.0.co;2-r

Source DB:  PubMed          Journal:  Eur J Immunol        ISSN: 0014-2980            Impact factor:   5.532


  23 in total

Review 1.  The many faces of host responses to tuberculosis.

Authors:  H L Collins; S H Kaufmann
Journal:  Immunology       Date:  2001-05       Impact factor: 7.397

2.  NK but not CD1-restricted NKT cells facilitate systemic inflammation during polymicrobial intra-abdominal sepsis.

Authors:  Anthony O Etogo; Jesus Nunez; Cheng Y Lin; Tracy E Toliver-Kinsky; Edward R Sherwood
Journal:  J Immunol       Date:  2008-05-01       Impact factor: 5.422

3.  HLA superfamily assignment is a predictor of immune response to cancer testis antigens and survival in ovarian cancer.

Authors:  J Brian Szender; Kevin H Eng; Junko Matsuzaki; Anthony Miliotto; Sacha Gnjatic; Takemasa Tsuji; Kunle Odunsi
Journal:  Gynecol Oncol       Date:  2016-04-23       Impact factor: 5.482

Review 4.  Vaccines for tuberculosis: novel concepts and recent progress.

Authors:  T Mark Doherty; Peter Andersen
Journal:  Clin Microbiol Rev       Date:  2005-10       Impact factor: 26.132

Review 5.  Mycobacterium tuberculosis-specific CD8+ T cells and their role in immunity.

Authors:  Joshua S M Woodworth; Samuel M Behar
Journal:  Crit Rev Immunol       Date:  2006       Impact factor: 2.214

6.  A multicistronic DNA vaccine induces significant protection against tuberculosis in mice and offers flexibility in the expressed antigen repertoire.

Authors:  Fayaz-Ahmad Mir; Stefan H E Kaufmann; Ali Nasser Eddine
Journal:  Clin Vaccine Immunol       Date:  2009-08-05

Review 7.  HLA and infectious diseases.

Authors:  Jenefer M Blackwell; Sarra E Jamieson; David Burgner
Journal:  Clin Microbiol Rev       Date:  2009-04       Impact factor: 26.132

8.  Poor correlation between BCG vaccination-induced T cell responses and protection against tuberculosis.

Authors:  Hans-Willi Mittrücker; Ulrich Steinhoff; Anne Köhler; Marion Krause; Doris Lazar; Peggy Mex; Delia Miekley; Stefan H E Kaufmann
Journal:  Proc Natl Acad Sci U S A       Date:  2007-07-18       Impact factor: 11.205

9.  Identification of murine H2-Dd- and H2-Ab-restricted T-cell epitopes on a novel protective antigen, MPT51, of Mycobacterium tuberculosis.

Authors:  Mina Suzuki; Taiki Aoshi; Toshi Nagata; Yukio Koide
Journal:  Infect Immun       Date:  2004-07       Impact factor: 3.441

10.  A critical role for CD8 T cells in a nonhuman primate model of tuberculosis.

Authors:  Crystal Y Chen; Dan Huang; Richard C Wang; Ling Shen; Gucheng Zeng; Shuyun Yao; Yun Shen; Lisa Halliday; Jeff Fortman; Milton McAllister; Jim Estep; Robert Hunt; Daphne Vasconcelos; George Du; Steven A Porcelli; Michelle H Larsen; William R Jacobs; Barton F Haynes; Norman L Letvin; Zheng W Chen
Journal:  PLoS Pathog       Date:  2009-04-17       Impact factor: 6.823

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.